DK0806933T3 - Præparater og fremgangsmåder til reduktion af hudirritation - Google Patents

Præparater og fremgangsmåder til reduktion af hudirritation

Info

Publication number
DK0806933T3
DK0806933T3 DK95944548T DK95944548T DK0806933T3 DK 0806933 T3 DK0806933 T3 DK 0806933T3 DK 95944548 T DK95944548 T DK 95944548T DK 95944548 T DK95944548 T DK 95944548T DK 0806933 T3 DK0806933 T3 DK 0806933T3
Authority
DK
Denmark
Prior art keywords
methods
skin irritation
preparations
reducing skin
compositions
Prior art date
Application number
DK95944548T
Other languages
English (en)
Inventor
Scott Hahn Gary
Orel Thueson David
Original Assignee
Cosmederm Technologies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23424697&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0806933(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cosmederm Technologies filed Critical Cosmederm Technologies
Application granted granted Critical
Publication of DK0806933T3 publication Critical patent/DK0806933T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06—Lipsticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/04—Preparations for permanent waving or straightening the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q9/00—Preparations for removing hair or for aiding hair removal
    • A61Q9/02—Shaving preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
DK95944548T 1994-12-21 1995-12-21 Præparater og fremgangsmåder til reduktion af hudirritation DK0806933T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/362,100 US5716625A (en) 1994-12-21 1994-12-21 Formulations and methods for reducing skin irritation
PCT/US1995/016985 WO1996019184A1 (en) 1994-12-21 1995-12-21 Formulations and methods for reducing skin irritation

Publications (1)

Publication Number Publication Date
DK0806933T3 true DK0806933T3 (da) 2003-01-06

Family

ID=23424697

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95944548T DK0806933T3 (da) 1994-12-21 1995-12-21 Præparater og fremgangsmåder til reduktion af hudirritation

Country Status (21)

Country Link
US (1) US5716625A (da)
EP (2) EP0806933B1 (da)
JP (1) JPH11502505A (da)
KR (1) KR100411837B1 (da)
CN (1) CN1162141C (da)
AT (2) ATE283032T1 (da)
AU (1) AU717182B2 (da)
BR (1) BR9510529A (da)
CA (1) CA2208246C (da)
CZ (1) CZ191497A3 (da)
DE (2) DE69527987T2 (da)
DK (1) DK0806933T3 (da)
ES (1) ES2181812T3 (da)
FI (1) FI972580L (da)
HU (1) HUT77099A (da)
MX (1) MX9704735A (da)
NO (1) NO317634B1 (da)
NZ (1) NZ301463A (da)
PL (1) PL184686B1 (da)
PT (1) PT806933E (da)
WO (1) WO1996019184A1 (da)

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721275A (en) * 1989-06-07 1998-02-24 Bazzano; Gail S. Slow release vehicles for minimizing skin irritancy of topical compositions
FR2719474B1 (fr) 1994-05-05 1996-05-31 Oreal Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue.
US6203803B1 (en) 1994-12-14 2001-03-20 Societe L'oreal S.A. Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained
FR2728265A1 (fr) * 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p dans une composition pharmaceutique
FR2728166A1 (fr) * 1994-12-19 1996-06-21 Oreal Composition topique contenant un antagoniste de substance p
US6139850A (en) * 1994-12-21 2000-10-31 Cosmederm Technologies Formulations and methods for reducing skin irritation
US7404967B2 (en) * 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
DE19504914C1 (de) * 1995-02-15 1995-11-16 Goldwell Gmbh Haarwaschmittel
FR2730930B1 (fr) * 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
EP0737471A3 (fr) * 1995-04-10 2000-12-06 L'oreal Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue
FR2732598B1 (fr) 1995-04-10 1997-05-09 Oreal Utilisation de sel de metaux alcalino-terreux pour le traitement des prurits et des dysesthesies oculaires ou palpebraux
FR2732603B1 (fr) * 1995-04-10 2001-06-29 Oreal Utilisation d'un sel de strontium comme antagoniste de substance p
ES2132855T3 (es) 1995-09-07 1999-08-16 Oreal Extracto de iridaceas y composiciones que lo contienen.
FR2738741B1 (fr) * 1995-09-19 1997-12-05 Oreal Composition pour la teinture des fibres keratiniques, contenant un antagoniste de substance p
FR2740342B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de manganese, de lithium, d'etain, de zinc ou d'yttrium, de cobalt, de baryum, de strontium dans des compositions pharmaceutiques
FR2740341B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau
FR2740335B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p
FR2754176B1 (fr) * 1996-10-07 1999-12-10 Roche Posay Lab Pharma Emulsion e/h a forte teneur en electrolytes et leur utilisation en dermo-cosmetique, notamment pour traiter les phenomenes d'irritation et/ou de peaux sensibles
US6168798B1 (en) * 1997-02-03 2001-01-02 Bristol-Myers Squibb Company Non-irritating composition for treating acne and other skin conditions
FR2762839B1 (fr) * 1997-04-30 2001-05-11 Oreal Nouveaux derives de l'acide salicylique et leur utilisation dans une composition cosmetique et/ou dermatologique
US6365634B1 (en) 1997-12-12 2002-04-02 C-P Technology Limited Partnership Naturally occurring compounds and their derivatives as cyclooxygenase 2 and/or 5-lipoxygenase inhibitors
JPH11180806A (ja) * 1997-12-22 1999-07-06 Kurita Water Ind Ltd 抗菌性組成物
KR19990054320A (ko) * 1997-12-26 1999-07-15 성재갑 곤충으로부터 인체를 보호하기 위한 조성물
US6036963A (en) * 1998-02-26 2000-03-14 Chesebrough-Ponds's Usa Co., Division Of Conopco, Inc. Gluconolactones and glucarolactones as anti-irritants in cosmetic compositions
US6143309A (en) * 1998-03-12 2000-11-07 Archimica (Florida), Inc. Delivery of hydroxy carboxylic acids
US6946144B1 (en) * 1998-07-08 2005-09-20 Oryxe Transdermal delivery system
US7220427B2 (en) * 1998-07-08 2007-05-22 Oryxe Mixture for transdermal delivery of low and high molecular weight compounds
FR2783706B1 (fr) 1998-09-25 2002-06-07 Oreal Composition aqueuse gelifiee stable a forte teneur en electrolyte
US5976514A (en) * 1998-11-20 1999-11-02 Procter & Gamble Company Low-irritation antiperspirant and deodorant compositions containing a volatile, nonpolar hydrocarbon liquid
US6383519B1 (en) * 1999-01-26 2002-05-07 Vita Special Purpose Corporation Inorganic shaped bodies and methods for their production and use
US6440432B1 (en) 1999-03-18 2002-08-27 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Skin cosmetic compositions containing dextran or maltodextrin and a weak carboxylic acid
US6294182B1 (en) 1999-03-18 2001-09-25 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Towelette product for minimizing facial fine lines and wrinkles
FR2793681B1 (fr) † 1999-05-18 2001-06-22 Oreal Utilisation d'au moins un inhibiteur d'au moins un canal calcique dans le traitement des rides
US6436429B1 (en) * 1999-06-28 2002-08-20 Gholam A. Peyman Process and composition for temporarily suppressing pain
US7223416B2 (en) * 1999-06-28 2007-05-29 Minu, L.L.C. Topical composition
US6726922B1 (en) 1999-06-28 2004-04-27 Minu, L.L.C. Process and composition for temporarily suppressing pain
US7744860B2 (en) * 1999-06-28 2010-06-29 Minu Llc Reduced bioirritant composition
FR2798855B1 (fr) * 1999-09-28 2003-04-25 Oreal Utilisation de complexes inorganiques-organiques dans une composition a usage topique
US20020082279A1 (en) * 1999-10-15 2002-06-27 Neal B. Schultz Method and composition for the treatment of dermatologic diseases
WO2001080827A2 (en) * 2000-04-21 2001-11-01 Nature's Cure Salicylic acid acne spray formulations and methods for treating acne with same
CA2413889C (en) 2000-06-26 2011-01-25 Playtex Products, Inc. Wipe with improved cleansing
DE10036799A1 (de) * 2000-07-28 2002-02-07 Beiersdorf Ag Neues Mittel zur Behandlung der Haare und der Kopfhaut
US7112334B2 (en) * 2001-06-05 2006-09-26 Freiberg Roberta C Allergy inhibition
US7157103B2 (en) 2001-08-06 2007-01-02 Euro-Celtique S.A. Pharmaceutical formulation containing irritant
NO20014746D0 (no) * 2001-09-28 2001-09-28 Clas M Kjoelberg Smertelindrende middel
US6737068B2 (en) 2001-10-01 2004-05-18 Playtex Products, Inc. Wipe formulation
WO2003039561A1 (en) * 2001-11-02 2003-05-15 Elan Corporation, Plc Pharmaceutical composition
KR100530669B1 (ko) * 2002-05-21 2005-11-23 주식회사 코리아나화장품 락테이트 및 감초 추출물을 포함하는 피부 미백용 화장료조성물
WO2004004645A2 (en) * 2002-07-10 2004-01-15 Armkell Llc. Composition for lessening malodors during hair treatment and hair removal and method of use
JP2004075549A (ja) * 2002-08-12 2004-03-11 Kanebo Ltd 化粧料
US7402323B2 (en) * 2002-08-21 2008-07-22 Akpharma, Inc. Compositions and methods for treating skin conditions
CA2499994C (en) * 2002-09-23 2012-07-10 Verion, Inc. Abuse-resistant pharmaceutical compositions
US20040115250A1 (en) * 2002-12-17 2004-06-17 Ansell Healthcare Products Inc. Camomile/aloe vera treated glove
EP1605955B1 (en) * 2003-03-27 2015-08-19 SantoSolve AS Anti-inflammatory composition based on strontium compounds
US20050085652A1 (en) * 2003-04-08 2005-04-21 Algorx Pharmaceuticals, Inc. Preparation and purification of synthetic capsaicin
US6902723B2 (en) * 2003-08-14 2005-06-07 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium
US6923952B2 (en) * 2003-08-14 2005-08-02 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium or calcium
US7582307B2 (en) 2003-11-26 2009-09-01 Harmony Labs, Inc. Dermatological composition
ATE521329T1 (de) * 2004-05-05 2011-09-15 Unilever Nv Säuregepufferte körperpflege zusammensetzungen
MXPA06015184A (es) 2004-06-23 2007-11-22 Nestec Sa Procedimiento y composiciones utiles para prevenir y/o tratar pieles sensibles y/o secas.
US7704522B2 (en) * 2004-09-08 2010-04-27 Clyde Morgan Topical medicament
EP1799196B1 (en) * 2004-10-08 2016-06-22 Forward Pharma A/S Controlled release pharmaceutical compositions comprising a fumaric acid ester
WO2006058140A2 (en) * 2004-11-24 2006-06-01 Algorx Pharmaceuticals, Inc. Capsaicinoid gel formulation and uses thereof
US20060140899A1 (en) * 2004-12-28 2006-06-29 Kimberly-Clark Worldwide, Inc. Skin cleansing system comprising an anti-adherent formulation and a cationic compound
US7642395B2 (en) * 2004-12-28 2010-01-05 Kimberly-Clark Worldwide, Inc. Composition and wipe for reducing viscosity of viscoelastic bodily fluids
US7749545B2 (en) * 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
US20060210514A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Skin protection and moisturizing compositions and method of making the same
US20060210524A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Skin care composition
US20060210515A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Hair growth formula
GB0518558D0 (en) * 2005-09-12 2005-10-19 Givaudan Sa Improvements in or related to organic compounds
US20070134232A1 (en) * 2005-12-14 2007-06-14 Joel Studin Topical bite care composition
US20070166273A1 (en) * 2006-01-19 2007-07-19 Krivulka Joseph J Skin treatment educational kit
PL2206494T3 (pl) 2006-03-31 2016-06-30 Stiefel Res Australia Pty Ltd Spienialny żel zawiesinowy
FR2902999B1 (fr) 2006-07-03 2012-09-28 Oreal Utilisation de derives c-glycoside a titre d'actif prodesquamant
US20080107743A1 (en) * 2006-11-02 2008-05-08 Akpharma Inc. Composition and method for enhancing skin cell growth, proliferation and repair
KR100812596B1 (ko) * 2006-12-15 2008-03-13 바이오스펙트럼 주식회사 천연 유래 화합물을 포함하는 피부보호 조성물
WO2008133868A1 (en) 2007-04-23 2008-11-06 Safe N' Simple Stoma wipe and adhesive remover and method
US8859021B2 (en) * 2007-05-14 2014-10-14 Sytheon Skin appearance through gene manipulation
US20090137534A1 (en) * 2007-11-26 2009-05-28 Chaudhuri Ratan K Skin treatment compositions and methods
WO2008154141A2 (en) * 2007-05-22 2008-12-18 Prelief Inc. Compositions and methods for preventing, minimizing and healing skin irritation and trauma
FR2918883B1 (fr) 2007-07-17 2010-01-15 Oreal Utilisation d'un extrait bacterien cultive sur une eau thermale pour le traitement des peaux seches
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2920304B1 (fr) 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
KR101169863B1 (ko) * 2007-11-28 2012-07-31 콜게이트-파아므올리브캄파니 오일의 알파 또는 베타 하이드록시 산 첨가생성물
US9445975B2 (en) * 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
UA125896C2 (uk) 2009-01-09 2022-07-06 Фвп Іп Апс Фармацевтичний склад, що містить в матриці, яка піддається ерозії, один або більше ефірів фумарової кислоти
FR2942719B1 (fr) 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
US8460687B1 (en) 2009-07-07 2013-06-11 Cosmoceutical Research Center Peeling compositions
WO2011010075A1 (fr) 2009-07-24 2011-01-27 L'oreal Utilisation d'un derive d'acide jasmonique en tant qu'agent apaisant
FR2968952A1 (fr) 2010-12-17 2012-06-22 Oreal Ester d'acide amine n-acyle a titre d'agent apaisant
CA2826073A1 (en) * 2011-02-03 2012-08-09 John E. Kulesza Skin renewal enhancer
EP2530068A1 (en) 2011-05-31 2012-12-05 Lacer, S.A. New strontium salts, synthesis and use thereof in the treatment of osteoporosis
US8475852B2 (en) 2011-10-26 2013-07-02 Javad Ghoreishi Topical therapeautic composition and palliative treatment method
US8741360B2 (en) 2011-10-26 2014-06-03 Javad Ghoreishi Topical therapeutic composition and palliative treatment method
CN103242391B (zh) * 2012-02-13 2016-04-13 南京华狮化工有限公司 一种制备甘草酸锶化合物的方法及其产品和应用
US9480704B2 (en) 2012-03-21 2016-11-01 Cosmederm Bioscience, Inc. Topically administered strontium-containing complexes for treating pain, pruritis and inflammation
KR101729096B1 (ko) * 2012-03-21 2017-04-21 코스메덤 바이오사이언스, 인코퍼레이티드 통증, 가려움증 및 염증을 치료하기 위한 국소 투여된 스트론튬-함유 복합체
EP2938324B1 (en) 2012-12-31 2023-11-08 JRX Biotechnology, Inc. Liquid topical pharmaceutical nano-emulsion formulations
US20170049807A1 (en) * 2015-08-21 2017-02-23 Cosmederm Bioscience, Inc. Strontium based compositions and formulations for pain, pruritus, and inflammation
US11235002B2 (en) 2015-08-21 2022-02-01 Galleon Labs Llc Strontium based compositions and formulations for pain, pruritus, and inflammation
EP3349717A4 (en) 2015-09-17 2019-04-17 JRX Biotechnology, Inc. APPROACHES TO IMPROVE SKIN HYDROGENATION OR HUMIDIFICATION
CN108291036A (zh) 2015-12-01 2018-07-17 金伯利-克拉克环球有限公司 包含弹性体共聚物的吸收性和保护性组合物
EP3369413A1 (en) * 2017-03-01 2018-09-05 The Boots Company PLC Cosmetic skincare compositions
AU2019251448B2 (en) 2018-04-09 2025-04-17 Noon Aesthetics M.R Ltd. Topical formulations comprising Strontium and Methylsulfonylmethane (MSM) and methods of treatment
CN111195259A (zh) * 2018-11-16 2020-05-26 深圳市阳光百度生物科技发展有限公司 一种氯化锶与d-泛醇复合制剂的制备方法及其抗敏修复的应用
CN111195213A (zh) * 2018-11-20 2020-05-26 广州市阳光美域日用品有限公司 一种氯化锶、多肽复合制剂的制备方法及应用
PL3986363T3 (pl) 2019-06-24 2026-03-16 WiQo S.P.A. Preparaty do stosowania odontologicznego i dermatologicznego zawierające sole trichlorooctanowe i hydroksykwasy
AU2019459969A1 (en) 2019-08-06 2022-03-24 Natura Cosméticos S.A. Topical cosmetic composition, use of the composition and serum for facial application
US12286451B2 (en) 2020-11-23 2025-04-29 Medtech Products Inc. Borate ester complexes of α-hydroxy carboxylic acids and their conjugate base buffers
IL308075A (en) * 2021-04-30 2023-12-01 Noon Aesthetics M R Ltd Skin preparations containing benzoyl peroxide and azelaic acid and their uses
CN114209687A (zh) * 2021-12-20 2022-03-22 重庆华邦制药有限公司 一种维a酸外用药物的组合物
CN115444766B (zh) * 2022-02-17 2023-06-20 中国科学院过程工程研究所 一种具有头皮滋养功效的双组分洗发水及其制备方法
CN116144189A (zh) * 2023-02-21 2023-05-23 中国乐凯集团有限公司 一种生物电的传导介质及其制备方法和应用
CN118593399B (zh) * 2024-06-17 2025-04-22 广州维特丝化妆品有限公司 一种具有舒敏和修复的复合物及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3716054A (en) * 1970-08-11 1973-02-13 W Porter Apparatus for applying medication to teeth and body tissue
US4105782A (en) * 1975-03-07 1978-08-08 Yu Ruey J Treatment of acne and dandruff
US4021572A (en) * 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
US4191750A (en) * 1976-03-08 1980-03-04 Milton Hodosh Method for treating canker sores
US4285973A (en) * 1979-07-20 1981-08-25 Alberto-Culver Company Liquid composition for application to the skin
US4477439A (en) * 1981-04-13 1984-10-16 Walter J. Monacelli Treatment of irritated and excoriated areas around the stoma of ostomy patients
EP0081492B1 (en) * 1981-06-12 1986-07-16 Rorer International (Overseas) Inc. Method and composition for treating acne
FR2590273A1 (fr) * 1985-09-20 1987-05-22 Brevier Christiane Produit nouveau resultant de l'association d'un micro-organisme marin, avec de l'eau de mer applique en produits esthetiques en dermatologie, en cosmetologie, en pharmacie
EP0217975B1 (de) * 1985-10-08 1991-12-04 Psori-Med Ag Salzmischung zur Behandlung der Schuppenflechte (Psoriasis) und anderer Hautkrankheiten
JPH0696512B2 (ja) * 1986-04-28 1994-11-30 鐘紡株式会社 非水系の温感皮膚化粧料
US4971800A (en) * 1988-07-08 1990-11-20 The Regents Of The University Of California Method and compositions for enhancing the cutaneous penetration of pharmacologically active agents
GB8811830D0 (en) * 1988-05-19 1988-06-22 Unilever Plc Oral compositions
US4879116A (en) * 1988-06-13 1989-11-07 Charles Fox Skin protein complexing composition for the potentiation of the substantivity of aluminum acetate through the use of a cationic emulsifier as an aid in skin healing
GB8906914D0 (en) * 1989-03-28 1989-05-10 Beecham Group Plc Novel compositions
JP2593714B2 (ja) * 1989-09-20 1997-03-26 株式会社 林原生物化学研究所 色白剤
AU697389B2 (en) * 1992-09-14 1998-10-01 Walter P. Smith Skin-conditioning composition its application and manufacture
EP0654270B1 (en) * 1993-11-22 2003-03-05 Bio.Life International AG. Preparation for the treatment of acne, seborrheic dermatitis and other skin diseases
DE4339750A1 (de) * 1993-11-22 1995-05-24 Biener Hans Mittel zur Behandlung von Akne, seborrhoischem Ekzem und anderen Hautkrankheiten
DE4339751A1 (de) * 1993-11-22 1995-05-24 Biener Hans Mittel zur Behandlung von Hautkrankheiten
ATE237298T1 (de) * 1994-12-21 2003-05-15 Cosmederm Technologies Formulierungen und verfahren zur verminderung von hautirritationen

Also Published As

Publication number Publication date
CA2208246A1 (en) 1996-06-27
KR100411837B1 (ko) 2004-05-10
FI972580A0 (fi) 1997-06-17
AU4689796A (en) 1996-07-10
NZ301463A (en) 2001-04-27
EP0806933B1 (en) 2002-08-28
FI972580A7 (fi) 1997-08-19
CN1162141C (zh) 2004-08-18
DE69533813D1 (de) 2004-12-30
NO972922L (no) 1997-08-21
NO972922D0 (no) 1997-06-20
PL320935A1 (en) 1997-11-10
DE69527987T2 (de) 2003-05-28
PT806933E (pt) 2003-01-31
ATE283032T1 (de) 2004-12-15
CN1175206A (zh) 1998-03-04
PL184686B1 (pl) 2002-11-29
EP1136065A1 (en) 2001-09-26
HK1004663A1 (en) 1998-12-04
HUT77099A (hu) 1998-03-02
DE69527987D1 (de) 2002-10-02
WO1996019184A1 (en) 1996-06-27
NO317634B1 (no) 2004-11-29
FI972580L (fi) 1997-08-19
ES2181812T3 (es) 2003-03-01
CA2208246C (en) 2009-11-17
ATE222744T1 (de) 2002-09-15
BR9510529A (pt) 1998-12-15
MX9704735A (es) 1998-06-30
AU717182B2 (en) 2000-03-16
JPH11502505A (ja) 1999-03-02
EP0806933A4 (en) 2000-02-23
EP0806933A1 (en) 1997-11-19
EP1136065B1 (en) 2004-11-24
DE69533813T2 (de) 2005-11-10
CZ191497A3 (en) 1997-11-12
US5716625A (en) 1998-02-10

Similar Documents

Publication Publication Date Title
DK0806933T3 (da) Præparater og fremgangsmåder til reduktion af hudirritation
DK0801554T3 (da) Formuleringer og fremgangsmåder til reduktion af hudirritation
FR2380266A1 (fr) Molybdates d'amines heterocycliques, procede d'obtention et application
NO304945B1 (no) Forbindelse og anvendelse derav for Õ regulere fethet i hud, samt kosmetisk blanding
DK0772600T3 (da) 1,2-substituerede imidazolylforbindelser til behandling af inflammation
BR9908869A (pt) Composição para evitar ou tratar distúrbios da pele
NO944430L (no) 4-mercaptoacetylamino-[2Åbenzazepinon(3)-derivater, og anvendelse som enkefalinaseinhibitorer
ATE69815T1 (de) Neue nitromethylen-derivate.
BG99177A (bg) Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза
DK0700898T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme, til behandling af dermatoser.
ES2092868T3 (es) Utilizacion de derivados de la 4-tiorresorcina en unas composiciones cosmeticas o dermofarmaceuticas de accion despigmentante.
AR013563A1 (es) Composiciones que continen derivados de hidroxianilina para combatir hongos daninos para las plantas y metodo para combatirlos con aplicacion de dichas composiciones
BG101002A (bg) Заместени арилалкилтио-алкилтиопиридини и използване за борба с бактерии от рода helicobacter
DE69502223D1 (de) Neue Verwendung von 1Alpha-fluor-25-hydroxy-16-en-23-yn-cholecalciferol
EA199900534A1 (ru) Имидазопиридазины
DK1107776T3 (da) Tørekstrakt af hennaplante, fremgangsmåde til fremstilling heraf og anvendelse heraf
DE69314463D1 (de) Hautregenerierende kosmetische zusammensetzung
FI960588A0 (fi) Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä
MX9305467A (es) Compuestos intermedios, quirales, de quinolona y procedimiento para su preparacion.
ATE253562T1 (de) Substituierte 2,4-diamino-1,3,5-triazine
PT971714E (pt) Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia
ES2173634T3 (es) Compuestos heterociclicos que presentan actividad inhibidora de mmp y tnf.
AR241135A2 (es) "derivados de n-triazinil-n-sulfamoilurea herbicidamente activos y formulacion herbicida que los contiene".
DE69428127D1 (de) Schädlingsbekämpfungsmittel
HRPK970026B1 (en) Olive resorbent